NASDAQ · Biotechnology

CervoMed Inc. (CRVO)

$2.57 -2.28%

Add alert

89 Overbought Daily RSI (14)

Moving averages

SMA 200$5.01-48.70%

Company profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. The company is headquartered in Boston, Massachusetts.

SectorHealthcare

IndustryBiotechnology

Market cap$41.28M

P/E ratioNone

EPS$-3.21

Beta-4.31

Dividend yield0.00%

52-week high$11.25

52-week low$2.13

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 52 VRTX Vertex Pharmaceuticals Inc RSI 64 CRSP CRISPR Therapeutics AG RSI 54 IOVA Iovance Biotherapeutics Inc RSI 66 RXRX Recursion Pharmaceuticals Inc - Class A RSI 51 MRNA Moderna Inc RSI 67 VKTX Viking Therapeutics Inc RSI 49 SRPT Sarepta Therapeutics Inc RSI 67 EDIT Editas Medicine Inc RSI 52 NVAX Novavax Inc RSI 72

Free forever

RSI alerts for CRVO

Get an email the moment CervoMed Inc. crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 16 August 2026 at 2:23 AM EDT